AI assistant
RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2019
Nov 29, 2019
30849_dirs_2019-11-29_ce563e0c-dfd2-420b-b61f-0bd66a9b7f75.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2019-11-26
Reporting Person: Foley Todd (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-26 | Common Stock | S | 74225 | $23.31 | Disposed | 2570355 | Indirect |
| 2019-11-27 | Common Stock | S | 34960 | $22.91 | Disposed | 2535395 | Indirect |
| 2019-11-29 | Common Stock | S | 18359 | $22.67 | Disposed | 2517036 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: Shares were sold as follows: 71,449 by BV V and 2,776 by AM BV5.
F3: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $22.71 to $23.56. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4: Shares are held as follows: 2,474,236 by BV V and 96,119 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F5: Shares were sold as follows: 33,653 by BV V and 1,307 by AM BV5.
F6: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $22.41 to $23.385. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7: Shares are held as follows: 2,440,583 by BV V and 94,812 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F8: Shares were sold as follows: 17,672 by BV V and 687 by AM BV5.
F9: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $22.36 to $22.95. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F10: Shares are held as follows: 2,422,911 by BV V and 94,125 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.